Treatment of Patients with Advanced Gastroesophageal Adenocarcinoma: Does Age Matter?

Related Articles Treatment of Patients with Advanced Gastroesophageal Adenocarcinoma: Does Age Matter? Drugs Aging. 2019 05;36(5):403-409 Authors: Lorenzen S, Hofheinz RD Abstract Gastroesophageal cancer is the fourth most frequent malignant disease and, despite significant advances in chemotherapy, the prognosis of unresectable or recurrent gastroesophageal cancer is poor. The majority of patients, nearly two-thirds, are over the age of 65 years at diagnosis. Elderly patients are a heterogeneous population and aging occurs at different rates in different individuals. The chronological age of a patient does not necessarily reflect the physiological age. However, elderly patients are more likely to have a number of…
Origen: Treatment of Patients with Advanced Gastroesophageal Adenocarcinoma: Does Age Matter? – PubMed